GGrantIndex
← Leaderboards

John L Sullivan

Therion Biologics Corporation

$12,806,871
Attributed
$12,806,871
Total exposure
18
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $7.4M · FY200511
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$26,567,586 · 22

By mechanism

UL1$13,570,204 · 7
P01$5,737,876 · 4
C06$2,324,886 · 2
U01$1,622,514 · 1
KL2$1,180,681 · 1
G20$635,000 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchCytotoxic T LymphocyteCellular ImmunityHuman Immunodeficiency Virus 1Human SubjectPathologic ProcessHerpesviridae DiseaseAids TherapyMicroorganism ImmunologyEpstein Barr VirusUniversitiesLeukocyte Activation /TransformationTranslational ResearchMassachusettsClinical Trial Phase IAids VaccinesVirus ProteinTissue /Cell CultureVertical TransmissionBiomedical FacilityHiv InfectionsPediatric AidsClinical SciencesAntigen Presenting Cell

Grant awards (37)

University of Massachusetts Center for Clinical and Translational Science$3,387,443
UL1 · FY2011 · RR · contact PI
UNIVERSITY OF MASSACHUSETTS CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE$2,540,582
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$677,489
UL1 · FY2011 · RR · contact PI
University of Massachusetts Center for Clinical and Translational Science$578,340
KL2 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$169,372
UL1 · FY2011 · RR · contact PI
University of Massachusetts Center for Clinical and Translational Science$3,397,659
UL1 · FY2010 · RR · contact PI
UNIVERSITY OF MASSACHUSETTS CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE$2,548,244
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$679,532
UL1 · FY2010 · RR · contact PI
University of Massachusetts Center for Clinical and Translational Science$602,341
KL2 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$169,883
UL1 · FY2010 · RR · contact PI
UMMS CLINICAL AND TRANSLATIONAL SCIENCE$242,472
P20 · FY2006 · RR · contact PI
UMMS Clinical and Translational Science$242,472
P20 · FY2006 · RR · contact PI
BIOCONTAINMENT SUITE RENOVATION TO ENHANCE RESEARCH: INFECTIOUS DISEASE$1,162,443
C06 · FY2005 · RR
Biocontainment Suite Renovation to Enhance Research$1,162,443
C06 · FY2005 · RR
Ontogeny &Maintenance of Virus Specific T Cells$1,099,679
P01 · FY2005 · AI
Ontogeny &Maintenance of Virus Specific T Cells$1,067,647
P01 · FY2004 · AI
EXPANSION AND CENTRALIZATION OF AQUATIC ANIMAL HOUSING$635,000
G20 · FY2004 · RR
Ontogeny &Maintenance of Virus Specific T Cells$1,036,550
P01 · FY2003 · AI
Quality Improvement through Electronic Enhancements$149,916
S07 · FY2003 · RR
Ontogeny &Maintenance of Virus Specific T Cells$1,403,087
P01 · FY2002 · AI
Quality Improvement in Human Subjects Research$114,262
S07 · FY2002 · RR
Ontogeny of EBV-Specific CTL: Infancy to Adolescence$0
P01 · FY2002 · AI
Core--Clinical Facility$0
P01 · FY2002 · AI
HIV 1 CELLULAR AND HUMORAL IMMUNE RESPONSES$0
P01 · FY2002 · AI
Ontogeny &Maintenance of Virus Specific T Cells$963,735
P01 · FY2001 · AI
PEDIATRIC AIDS CLINICAL TRIAL UNIT$818,332
U01 · FY2001 · AI
IMMUNOREGULATORY DEFECTS IN HEMOPHILIA$305,358
R01 · FY2001 · HL
HIV 1 CELLULAR AND HUMORAL IMMUNE RESPONSES$0
P01 · FY2001 · AI
CORE--ADULT AND PEDIATRIC CLINICAL$0
P30 · FY2001 · AI
Core--Clinical Facility$0
P01 · FY2001 · AI
Ontogeny of EBV-Specific CTL: Infancy to Adolescence$0
P01 · FY2001 · AI
HIV 1 CELLULAR AND HUMORAL IMMUNE RESPONSES$0
P01 · FY2001 · AI
PEDIATRIC AIDS CLINICAL TRIAL UNIT$804,182
U01 · FY2000 · AI
IMMUNOREGULATORY DEFECTS IN HEMOPHILIA$298,165
R01 · FY2000 · HL
HIV 1 CELLULAR AND HUMORAL IMMUNE RESPONSES$167,178
P01 · FY2000 · AI
CORE--ADULT AND PEDIATRIC CLINICAL$116,830
P30 · FY2000 · AI
TUBERCULOSIS AND VERTICLE HIV1 INFECTION$26,950
R03 · FY2000 · TW